Measuring the accuracy of propofol target-controlled infusion (TCI) before and after surgery with major blood loss.


Journal

Journal of clinical monitoring and computing
ISSN: 1573-2614
Titre abrégé: J Clin Monit Comput
Pays: Netherlands
ID NLM: 9806357

Informations de publication

Date de publication:
Feb 2020
Historique:
received: 07 08 2018
accepted: 17 01 2019
pubmed: 24 1 2019
medline: 16 6 2021
entrez: 24 1 2019
Statut: ppublish

Résumé

Target-controlled infusion (TCI) is based on pharmacokinetic models designed to achieve a desired drug level in the blood. TCI's predictive accuracy of plasma propofol levels at the end of surgery with major blood loss has not been well established. This prospective observational study included adult patients (BMI 20-35 kg/m

Identifiants

pubmed: 30671895
doi: 10.1007/s10877-019-00261-8
pii: 10.1007/s10877-019-00261-8
doi:

Substances chimiques

Anesthetics, Intravenous 0
Lactic Acid 33X04XA5AT
Propofol YI7VU623SF

Banques de données

DRKS
['DRKS00009312']

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

97-103

Références

Anesth Analg. 2016 Jan;122(1):79-85
pubmed: 26516801
Anesthesiology. 2000 Feb;92(2):399-406
pubmed: 10691226
Br J Anaesth. 2011 Jul;107(1):38-47
pubmed: 21624964
Anaesthesia. 2019 Feb;74(2):211-224
pubmed: 30378102
Anaesthesia. 1998 Apr;53 Suppl 1:13-21
pubmed: 9640110
Anesth Analg. 2016 Jan;122(1):56-69
pubmed: 26516804
Br J Anaesth. 2011 Oct;107(4):593-600
pubmed: 21743068
Anaesthesia. 1998 Apr;53 Suppl 1:61-7
pubmed: 9640119
Anesth Analg. 2006 Feb;102(2):430-7
pubmed: 16428538
Br J Anaesth. 2017 Jun 1;118(6):901-909
pubmed: 28549082
Anesth Analg. 2014 Aug;119(2):302-10
pubmed: 24977639
Eur J Anaesthesiol. 2013 Oct;30(10):627-32
pubmed: 23962821
Br J Anaesth. 2009 May;102(5):626-32
pubmed: 19297371
Br J Anaesth. 2009 Jul;103(1):26-37
pubmed: 19520702
Br J Anaesth. 1991 Mar;66(3):331-9
pubmed: 1901724
Anaesthesist. 2018 Feb;67(2):147-162
pubmed: 29335823
J Clin Pharmacol. 2018 May;58(5):606-612
pubmed: 29315660

Auteurs

Thomas Mohler (T)

Institute of Anaesthesia and Intensive Care Medicine, Spital Thurgau, Pfaffenholzstrasse 4, 8501, Frauenfeld, Switzerland.

JoEllen Welter (J)

Institute of Anaesthesia and Intensive Care Medicine, Spital Thurgau, Pfaffenholzstrasse 4, 8501, Frauenfeld, Switzerland.

Martina Steurer (M)

Department of Pediatrics, University of California, San Francisco, USA.

Luis Neumann (L)

Institute of Anaesthesia and Intensive Care Medicine, Spital Thurgau, Pfaffenholzstrasse 4, 8501, Frauenfeld, Switzerland.

Max Zueger (M)

Institute of Laboratory Medicine, Spital Thurgau, Frauenfeld, Switzerland.

Thomas Kraemer (T)

Forensic Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland.

Alexander Dullenkopf (A)

Institute of Anaesthesia and Intensive Care Medicine, Spital Thurgau, Pfaffenholzstrasse 4, 8501, Frauenfeld, Switzerland. alexander.dullenkopf@stgag.ch.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH